There have been 50 recent insider transactions recorded for Alumis Inc. Common Stock (ALMS), including 46 buys and 3 sells. Total insider buying was valued at $94.64M and total insider selling at RSU Award.
Notable insiders with recent activity include Tananbaum James B., Foresite Capital Management Vi Llc, Foresite Labs, Llc. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.
Insider Transactions — ALMS
| Date |
Name |
Role |
Transaction |
Shares |
Avg. Price |
Value |
Shares Owned |
| 2026-04-01 |
Tananbaum James B. |
10 Percent Owner |
Other (Sell) |
1,123,337 |
- |
- |
- |
| 2026-04-01 |
Foresite Capital Management Vi Llc |
10 Percent Owner |
Other (Sell) |
1,123,337 |
- |
- |
- |
| 2026-04-01 |
Foresite Labs, Llc |
10 Percent Owner |
Other (Sell) |
1,123,337 |
- |
- |
- |
| 2026-01-26 |
Babler Martin |
President, CEO and Chairman |
RSU Award |
745,875 |
$26.31 |
$19.62M |
745,875 |
| 2026-01-26 |
Hardiman Roy C. |
Chief Business & Strategy Ofcr |
RSU Award |
190,875 |
$26.31 |
$5.02M |
190,875 |
| 2026-01-26 |
Schroer John R. |
Chief Financial Officer |
RSU Award |
202,225 |
$26.31 |
$5.32M |
202,225 |
| 2026-01-26 |
Goldstein David M |
Chief Scientific Officer |
RSU Award |
216,675 |
$26.31 |
$5.7M |
216,675 |
| 2026-01-26 |
Drappa Jorn |
Chief Medical Officer |
RSU Award |
221,450 |
$26.31 |
$5.83M |
221,450 |
| 2026-01-26 |
Bradley Mark Christopher |
Chief Development Officer |
RSU Award |
190,225 |
$26.31 |
$5M |
190,225 |
| 2026-01-26 |
Pangali Sanam |
Chief Legal Officer |
RSU Award |
186,200 |
$26.31 |
$4.9M |
186,200 |
| 2026-01-09 |
Akkaraju Srinivas |
Director |
Informative Buy |
588,235 |
$17.00 |
$10M |
1,853,488 |
| 2026-01-08 |
Tananbaum James B. |
10 Percent Owner |
Informative Buy |
294,117 |
$17.00 |
$5M |
2,908,332 |
| 2026-01-08 |
Foresite Capital Management Vi Llc |
10 Percent Owner |
Informative Buy |
294,117 |
$17.00 |
$5M |
2,908,332 |
| 2026-01-08 |
Foresite Labs, Llc |
10 Percent Owner |
Informative Buy |
294,117 |
$17.00 |
$5M |
2,908,332 |
| 2025-12-31 |
Goldstein David M |
Chief Scientific Officer |
Unknown |
- |
- |
- |
8,994 |
| 2025-12-05 |
Akkaraju Srinivas |
Director |
Informative Buy |
64,969 |
$8.95 |
$581.47K |
1,143,845 |
| 2025-12-04 |
Akkaraju Srinivas |
Director |
Informative Buy |
66,027 |
$8.18 |
$540.1K |
1,078,876 |
| 2025-12-03 |
Akkaraju Srinivas |
Director |
Informative Buy |
100,000 |
$7.75 |
$775K |
1,012,849 |
| 2025-12-02 |
Akkaraju Srinivas |
Director |
Informative Buy |
96,000 |
$7.55 |
$724.8K |
912,849 |
| 2025-12-01 |
Akkaraju Srinivas |
Director |
Informative Buy |
86,350 |
$7.46 |
$644.17K |
816,849 |
| 2025-11-28 |
Akkaraju Srinivas |
Director |
Informative Buy |
38,702 |
$7.64 |
$295.68K |
730,499 |
| 2025-11-26 |
Akkaraju Srinivas |
Director |
Informative Buy |
48,537 |
$7.64 |
$370.82K |
691,797 |
| 2025-11-21 |
Tananbaum James B. |
10 Percent Owner |
Informative Buy |
72,212 |
$7.38 |
$532.92K |
2,614,215 |
| 2025-11-21 |
Foresite Capital Management Vi Llc |
10 Percent Owner |
Informative Buy |
72,212 |
$7.38 |
$532.92K |
2,614,215 |
| 2025-11-21 |
Foresite Labs, Llc |
10 Percent Owner |
Informative Buy |
72,212 |
$7.38 |
$532.92K |
2,614,215 |
| 2025-11-20 |
Akkaraju Srinivas |
Director |
Informative Buy |
125,743 |
$7.20 |
$905.35K |
643,260 |
| 2025-11-19 |
Akkaraju Srinivas |
Director |
Informative Buy |
137,772 |
$6.56 |
$903.78K |
517,517 |
| 2025-11-19 |
Tananbaum James B. |
10 Percent Owner |
Informative Buy |
190,500 |
$6.56 |
$1.25M |
2,542,003 |
| 2025-11-19 |
Foresite Capital Management Vi Llc |
10 Percent Owner |
Informative Buy |
190,500 |
$6.56 |
$1.25M |
2,542,003 |
| 2025-11-19 |
Foresite Labs, Llc |
10 Percent Owner |
Informative Buy |
190,500 |
$6.56 |
$1.25M |
2,542,003 |
| 2025-11-18 |
Akkaraju Srinivas |
Director |
Informative Buy |
102,652 |
$6.05 |
$621.04K |
379,745 |
| 2025-11-18 |
Tananbaum James B. |
10 Percent Owner |
Informative Buy |
117,374 |
$6.19 |
$726.55K |
2,351,503 |
| 2025-11-18 |
Foresite Capital Management Vi Llc |
10 Percent Owner |
Informative Buy |
117,374 |
$6.19 |
$726.55K |
2,351,503 |
| 2025-11-18 |
Foresite Labs, Llc |
10 Percent Owner |
Informative Buy |
117,374 |
$6.19 |
$726.55K |
2,351,503 |
| 2025-11-17 |
Akkaraju Srinivas |
Director |
Informative Buy |
914 |
$5.51 |
$5.04K |
277,093 |
| 2025-11-17 |
Tananbaum James B. |
10 Percent Owner |
Informative Buy |
50,000 |
$5.60 |
$280K |
2,084,129 |
| 2025-11-17 |
Foresite Capital Management Vi Llc |
10 Percent Owner |
Informative Buy |
50,000 |
$5.60 |
$280K |
2,084,129 |
| 2025-11-17 |
Foresite Labs, Llc |
10 Percent Owner |
Informative Buy |
50,000 |
$5.60 |
$280K |
2,084,129 |
| 2025-11-13 |
Akkaraju Srinivas |
Director |
Informative Buy |
276,179 |
$5.25 |
$1.45M |
276,179 |
| 2025-07-30 |
Akkaraju Srinivas |
Director |
RSU Award |
49,800 |
$4.10 |
$204.18K |
49,800 |
| 2025-07-30 |
Machado Patrick |
Director |
RSU Award |
49,800 |
$4.10 |
$204.18K |
49,800 |
| 2025-07-30 |
Yao Zhengbin |
Director |
RSU Award |
49,800 |
$4.10 |
$204.18K |
49,800 |
| 2025-07-30 |
Srivastava Sapna |
Director |
RSU Award |
49,800 |
$4.10 |
$204.18K |
49,800 |
| 2025-07-30 |
Tetrault Lynn A. |
Director |
RSU Award |
49,800 |
$4.10 |
$204.18K |
49,800 |
| 2025-07-29 |
Babler Martin |
President, CEO and Chairman |
RSU Award |
150,000 |
$3.95 |
$592.5K |
150,000 |
| 2025-07-29 |
Hardiman Roy C. |
Chief Business & Strategy Ofcr |
RSU Award |
111,950 |
$3.95 |
$442.2K |
111,950 |
| 2025-07-29 |
Schroer John R. |
Chief Financial Officer |
RSU Award |
28,000 |
- |
- |
28,000 |
| 2025-07-29 |
Goldstein David M |
Chief Scientific Officer |
RSU Award |
27,000 |
- |
- |
29,115 |
| 2025-07-29 |
Drappa Jorn |
Chief Medical Officer |
RSU Award |
25,450 |
- |
- |
28,450 |
| 2025-07-29 |
Richardson Derrick |
SVP, People and Culture |
RSU Award |
42,800 |
- |
- |
42,800 |
■ Informative Buy/Sell — open market transaction (most significant)
■ Uninformative Buy — award, option exercise, conversion
■ Uninformative Sell — tax withholding, award vest sale
■ Neutral — gift, trust, expiry
